Figure 1From: Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro Antitumor effects of sunitinib malate, sorafenib and cisplatin on the 3 human bladder cancer cell lines following exposure to graded concentrations of 0.625-20 μmol/L of the 3 drugs for 24–96 hours (MTT assay). Back to article page